Nifty
Sensex
:
:
16266.15
54326.39
456.75 (2.89%)
1534.16 (2.91%)

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 524689 | NSE: PDPL

Not traded in the last 30 days
  • Open
  • High
  • Low
  • Previous Close
  •  N/A
  •  N/A
  •  N/A
  •  N/A
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  N/A
  •  N/A
  •  N/A
  •  N/A

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11.03
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 646.56
  • N/A
  • -0.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.29%
  • 3.01%
  • 21.74%
  • FII
  • DII
  • Others
  • 0%
  • 0.01%
  • 1.95%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -28.16
  • -44.43
  • -27.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -12.06
  • -7.79

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.59
  • 0.65
  • -6.29

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -0.70
  • -0.33
  • -0.02

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -14.68
  • -53.14
  • -54.46

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
1.44
2.04
-29.41%
2.35
4.64
-49.35%
2.93
2.92
0.34%
2.60
8.79
-70.42%
Expenses
4.67
4.91
-4.89%
5.62
11.11
-49.41%
6.19
8.75
-29.26%
-0.82
12.67
-
EBITDA
-3.22
-2.87
-
-3.27
-6.47
-
-3.26
-5.83
-
3.42
-3.88
-
EBIDTM
-223.65%
-140.94%
-139.15%
-139.34%
-111.33%
-199.59%
131.65%
-44.16%
Other Income
0.01
0.01
0.00%
0.01
0.01
0.00%
0.01
0.01
0.00%
0.00
0.00
0
Interest
36.68
32.09
14.30%
35.46
31.03
14.28%
34.10
29.85
14.24%
32.46
28.72
13.02%
Depreciation
4.33
4.34
-0.23%
4.33
4.34
-0.23%
3.70
4.34
-14.75%
4.32
4.32
0.00%
PBT
-44.23
-39.29
-
-43.05
-41.82
-
-41.05
-40.00
-
-33.36
-36.92
-
Tax
-9.70
-8.31
-
-9.44
-8.15
-
-9.02
-7.78
-
-8.52
-4.98
-
PAT
-34.52
-30.98
-
-33.61
-33.67
-
-32.04
-32.22
-
-24.84
-31.94
-
PATM
-2,394.24%
-1,520.62%
-1,430.38%
-725.60%
-1,093.07%
-1,103.70%
-956.64%
-363.43%
EPS
-11.58
-10.39
-
-11.27
-11.29
-
-10.74
-10.81
-
-8.33
-10.71
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
9.32
12.17
31.87
32.01
223.91
229.75
260.27
262.67
273.70
327.43
332.51
Net Sales Growth
-49.32%
-61.81%
-0.44%
-85.70%
-2.54%
-11.73%
-0.91%
-4.03%
-16.41%
-1.53%
 
Cost Of Goods Sold
4.97
5.66
6.32
6.46
143.98
153.96
183.70
126.44
164.78
194.10
180.76
Gross Profit
4.35
6.50
25.55
25.55
79.93
75.79
76.57
136.23
108.92
133.33
151.75
GP Margin
46.63%
53.41%
80.17%
79.82%
35.70%
32.99%
29.42%
51.86%
39.80%
40.72%
45.64%
Total Expenditure
15.66
23.94
46.56
49.67
225.09
252.13
296.02
248.36
349.63
341.45
318.59
Power & Fuel Cost
-
0.71
9.57
10.87
11.67
12.21
12.48
15.01
14.63
16.72
11.80
% Of Sales
-
5.83%
30.03%
33.96%
5.21%
5.31%
4.80%
5.71%
5.35%
5.11%
3.55%
Employee Cost
-
14.51
19.21
19.94
21.93
20.82
16.87
23.58
24.95
21.28
24.62
% Of Sales
-
119.23%
60.28%
62.29%
9.79%
9.06%
6.48%
8.98%
9.12%
6.50%
7.40%
Manufacturing Exp.
-
0.94
6.80
7.09
10.98
11.57
21.74
21.85
32.00
35.70
19.46
% Of Sales
-
7.72%
21.34%
22.15%
4.90%
5.04%
8.35%
8.32%
11.69%
10.90%
5.85%
General & Admin Exp.
-
1.93
4.09
5.22
14.11
25.58
27.17
25.60
29.16
29.02
37.28
% Of Sales
-
15.86%
12.83%
16.31%
6.30%
11.13%
10.44%
9.75%
10.65%
8.86%
11.21%
Selling & Distn. Exp.
-
0.14
0.14
0.24
19.08
7.14
9.79
35.80
37.64
44.41
44.15
% Of Sales
-
1.15%
0.44%
0.75%
8.52%
3.11%
3.76%
13.63%
13.75%
13.56%
13.28%
Miscellaneous Exp.
-
0.05
0.44
-0.15
3.33
20.86
24.27
0.07
46.47
0.20
44.15
% Of Sales
-
0.41%
1.38%
-0.47%
1.49%
9.08%
9.32%
0.03%
16.98%
0.06%
0.16%
EBITDA
-6.33
-11.77
-14.69
-17.66
-1.18
-22.38
-35.75
14.31
-75.93
-14.02
13.92
EBITDA Margin
-67.92%
-96.71%
-46.09%
-55.17%
-0.53%
-9.74%
-13.74%
5.45%
-27.74%
-4.28%
4.19%
Other Income
0.03
0.06
0.25
1.44
1.59
5.75
2.05
0.96
60.77
0.25
0.44
Interest
138.70
125.44
109.96
96.05
97.54
85.77
69.88
70.25
60.21
55.85
48.41
Depreciation
16.68
17.33
17.35
69.12
24.24
24.89
22.79
30.98
18.62
23.00
14.47
PBT
-161.69
-154.47
-141.74
-181.40
-121.37
-127.29
-126.36
-85.95
-94.00
-92.62
-48.52
Tax
-36.68
-32.76
-27.66
-33.49
-9.56
-9.56
-10.36
-18.70
-1.39
15.22
4.84
Tax Rate
22.69%
21.21%
19.51%
18.46%
7.88%
7.50%
8.16%
21.65%
2.99%
-16.43%
-9.98%
PAT
-125.01
-121.71
-114.07
-147.91
-111.81
-117.83
-116.55
-67.66
-45.17
-107.84
-53.38
PAT before Minority Interest
-125.01
-121.71
-114.07
-147.91
-111.81
-117.83
-116.55
-67.66
-45.17
-107.84
-53.36
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.02
PAT Margin
-1,341.31%
-1000.08%
-357.92%
-462.07%
-49.94%
-51.29%
-44.78%
-25.76%
-16.50%
-32.94%
-16.05%
PAT Growth
0.00%
-
-
-
-
-
-
-
-
-
 
EPS
-41.95
-40.84
-38.28
-49.63
-37.52
-39.54
-39.11
-22.70
-15.16
-36.19
-17.91

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
-682.88
-561.31
-446.92
-136.44
-17.44
325.38
127.10
202.33
246.22
349.06
Share Capital
29.82
29.82
29.82
29.82
29.82
47.70
45.20
45.20
43.24
37.83
Total Reserves
-712.69
-591.12
-476.74
-166.25
-47.26
277.68
81.90
157.13
191.98
272.00
Non-Current Liabilities
-58.51
-25.79
4.47
370.10
461.57
440.18
427.02
455.62
426.79
245.56
Secured Loans
0.00
0.00
0.00
252.72
323.96
379.40
328.32
359.71
358.89
201.43
Unsecured Loans
107.20
107.20
109.67
181.12
179.21
56.40
83.96
62.44
30.36
21.59
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
1,143.64
1,005.70
877.55
592.56
427.55
299.78
229.77
165.98
161.66
254.23
Trade Payables
7.81
7.93
11.87
51.20
42.58
38.91
61.24
44.73
59.72
77.98
Other Current Liabilities
1,125.52
988.31
857.30
379.59
223.61
100.28
58.31
36.78
12.99
11.59
Short Term Borrowings
0.00
0.00
0.00
153.36
153.12
152.21
101.54
73.98
83.64
159.91
Short Term Provisions
10.31
9.46
8.38
8.41
8.25
8.37
8.68
10.49
5.31
4.75
Total Liabilities
402.37
418.72
435.22
826.50
871.96
1,065.99
784.54
824.58
835.32
849.50
Net Block
321.81
339.14
356.49
715.80
738.66
891.82
542.42
570.97
609.95
499.97
Gross Block
786.36
786.36
786.36
915.41
914.02
1,042.30
670.10
668.42
696.00
563.12
Accumulated Depreciation
464.55
447.22
429.88
199.60
175.36
150.47
127.68
97.45
86.04
63.15
Non Current Assets
334.30
351.26
367.91
727.46
750.26
901.99
548.82
619.14
628.93
629.90
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.87
4.23
116.27
Non Current Investment
2.40
2.40
2.40
0.00
0.52
0.02
0.01
0.03
0.03
0.03
Long Term Loans & Adv.
7.48
7.21
6.54
8.09
6.79
10.15
6.39
47.28
14.72
13.62
Other Non Current Assets
2.61
2.51
2.49
3.56
4.29
0.00
0.00
0.00
0.00
0.00
Current Assets
68.07
67.47
67.31
99.05
121.70
163.15
234.86
199.96
192.10
201.45
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1.59
1.26
3.97
27.01
45.05
56.27
80.27
57.69
64.26
73.91
Sundry Debtors
0.00
0.00
0.00
3.66
62.33
92.42
139.37
120.49
78.95
91.90
Cash & Bank
0.06
0.11
0.45
3.55
3.23
4.57
3.08
8.24
10.50
13.33
Other Current Assets
66.42
56.70
56.70
56.70
11.09
9.89
12.14
13.54
38.38
22.31
Short Term Loans & Adv.
9.72
9.40
6.19
8.12
11.09
9.54
11.69
13.29
38.16
21.81
Net Current Assets
-1,075.57
-938.24
-810.24
-493.52
-305.85
-136.63
5.09
33.99
30.44
-52.78
Total Assets
402.37
418.73
435.22
826.51
871.96
1,065.99
784.55
824.57
835.33
849.50

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
125.32
112.36
477.03
166.95
134.40
57.97
1.65
-60.20
-167.50
19.63
PBT
-154.47
-141.74
-181.40
-141.25
-127.39
-126.36
-85.95
-94.00
-92.62
-48.52
Adjustment
143.75
127.88
164.70
121.82
109.51
92.67
101.23
78.83
79.34
63.37
Changes in Working Capital
136.05
126.22
472.76
186.38
152.20
139.44
64.63
-38.37
-98.16
53.45
Cash after chg. in Working capital
125.32
112.36
456.06
166.95
134.32
105.75
79.90
-53.54
-111.44
68.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
-69.88
-70.25
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
-0.02
0.00
-0.03
-2.69
-0.22
-0.26
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
20.98
0.00
0.10
22.10
-7.97
0.00
0.00
0.00
Cash From Investing Activity
0.06
0.08
96.58
-0.62
-0.54
-110.00
3.05
32.56
-17.59
-147.02
Net Fixed Assets
0.00
0.00
0.01
-1.35
-0.01
-371.70
-2.05
-9.68
-7.47
-35.25
Net Investments
0.00
0.00
0.00
0.47
135.64
0.54
0.41
0.00
0.00
0.00
Others
0.06
0.08
96.57
0.26
-136.17
261.16
4.69
42.24
-10.12
-111.77
Cash from Financing Activity
-125.44
-112.43
-573.59
-166.62
-134.35
53.51
-9.86
25.39
182.26
132.54
Net Cash Inflow / Outflow
-0.05
0.01
0.02
-0.28
-0.48
1.49
-5.16
-2.26
-2.83
5.15
Opening Cash & Equivalents
0.11
0.10
0.08
0.36
0.84
3.08
8.24
10.50
13.33
8.18
Closing Cash & Equivalent
0.06
0.11
0.10
0.08
0.36
4.57
3.08
8.24
10.50
13.33

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
-253.19
-212.42
-174.06
-134.09
-94.18
14.51
36.78
60.46
78.23
107.67
ROA
-29.65%
-26.72%
-23.45%
-13.17%
-12.16%
-12.60%
-8.41%
-5.44%
-12.80%
-6.65%
ROE
0.00%
0.00%
0.00%
0.00%
0.00%
-152.43%
-46.67%
-23.61%
-44.85%
-18.43%
ROCE
0.00%
-52.31%
-35.07%
-5.55%
-6.91%
-8.13%
-2.29%
1.90%
-5.15%
-0.02%
Fixed Asset Turnover
0.02
0.04
0.04
0.25
0.24
0.32
0.41
0.42
0.54
0.67
Receivable days
0.00
0.00
0.00
53.24
118.09
154.45
171.12
128.21
91.76
106.99
Inventory Days
42.69
29.92
176.56
58.14
77.32
90.99
90.86
78.40
74.21
88.41
Payable days
507.33
571.75
100.11
80.00
64.37
74.10
69.65
65.04
76.76
88.78
Cash Conversion Cycle
-464.64
-541.83
76.45
31.38
131.05
171.33
192.33
141.57
89.20
106.62
Total Debt/Equity
-0.84
-1.00
-1.23
-1.92
-2.75
10.66
4.52
2.68
2.20
1.32
Interest Cover
-0.23
-0.29
-0.89
-0.24
-0.49
-0.82
-0.23
0.23
-0.66
0.00

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.